Lv1
100 积分 2025-08-22 加入
A Neutral Risk Framework for Active Participation Across the Lifespan: A Call to Action for Using Risk in Movement Contexts as a Tool for Human Flourishing
1个月前
已完结
Generic Drug Shortage in Japan: GMP Noncompliance and Associated Quality Issues
1个月前
已完结
Characteristics and Outcomes of Anaphylaxis in Emergency Department Visits Among Older Adults
3个月前
已关闭
24th ISoP Annual Meeting “Pharmacovigilance: Back to the Future” 24–27 October 2025 Cairo, Egypt
3个月前
已完结
Disproportionality Analysis and Causal Inference in Drug Safety
5个月前
已完结
钠-葡萄糖共转运蛋白2抑制剂致围术期非高血糖型酮症酸中毒文献病例分析
5个月前
已关闭
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement
5个月前
已完结
Semaglutide: First Global Approval
5个月前
已完结
Artificial intelligence-driven pharmacovigilance analysis of polypharmacy and adverse events in breast cancer survivors treated with antidepressants
5个月前
已关闭
Safety issues with glucagon‐like peptide‐1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials
5个月前
已完结
皖公网安备34019202002308
